LMR Partners LLP Has $1,887,000 Stake in HCA Holdings Inc. (HCA)
LMR Partners LLP decreased its stake in HCA Holdings Inc. (NYSE:HCA) by 88.3% during the second quarter, Holdings Channel reports. The institutional investor owned 24,501 shares of the company’s stock after selling 184,963 shares during the period. LMR Partners LLP’s holdings in HCA Holdings were worth $1,887,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Acrospire Investment Management LLC purchased a new position in shares of HCA Holdings during the first quarter valued at $109,000. NN Investment Partners Holdings N.V. purchased a new position in shares of HCA Holdings during the first quarter valued at $148,000. Invictus RG increased its position in shares of HCA Holdings by 21.9% in the first quarter. Invictus RG now owns 2,156 shares of the company’s stock valued at $168,000 after buying an additional 388 shares during the period. Bremer Trust National Association purchased a new position in shares of HCA Holdings during the second quarter valued at $239,000. Finally, Parametrica Management Ltd purchased a new position in shares of HCA Holdings during the second quarter valued at $273,000. Institutional investors own 72.83% of the company’s stock.
HCA Holdings Inc. (NYSE:HCA) traded down 0.19% during mid-day trading on Thursday, reaching $74.60. 1,790,731 shares of the company’s stock were exchanged. The stock has a market cap of $28.25 billion, a P/E ratio of 12.93 and a beta of 0.89. HCA Holdings Inc. has a 52 week low of $60.07 and a 52 week high of $83.69. The stock has a 50-day moving average price of $75.45 and a 200-day moving average price of $77.64.
HCA Holdings (NYSE:HCA) last issued its quarterly earnings data on Thursday, July 28th. The company reported $1.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.56 by $0.10. The company earned $10.32 billion during the quarter, compared to analysts’ expectations of $10.49 billion. HCA Holdings had a negative return on equity of 42.19% and a net margin of 5.75%. The business’s revenue was up 4.3% on a year-over-year basis. During the same period last year, the business earned $1.37 earnings per share. On average, analysts forecast that HCA Holdings Inc. will post $6.59 earnings per share for the current year.
Several research analysts have recently weighed in on HCA shares. Mizuho restated a “buy” rating and issued a $102.00 target price on shares of HCA Holdings in a research note on Thursday, July 14th. Zacks Investment Research upgraded shares of HCA Holdings from a “hold” rating to a “buy” rating and set a $85.00 target price for the company in a research note on Tuesday, July 5th. Credit Suisse Group AG reaffirmed a “buy” rating on shares of HCA Holdings in a report on Tuesday, June 28th. Finally, Jefferies Group reaffirmed a “buy” rating on shares of HCA Holdings in a report on Wednesday, August 10th. Eight equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. HCA Holdings presently has a consensus rating of “Buy” and an average price target of $86.88.
About HCA Holdings
HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings Inc. (NYSE:HCA).
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.